Article Information
History
- March 10, 2021.
Article Versions
- You are currently viewing Version 1 of this article (March 10, 2021 - 09:42).
- View Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- María Velasco1,*,
- Ma Isabel Galán2,
- Ma Luisa Casas3,
- Elia Pérez-Fernández4,
- Beatriz González-Piñeiro5,
- Virgilio Castilla6,
- Carlos Guijarro7,†,
- Working Group Alcorcón COVID-19
- 1Infectious Diseases and Research Unit, Hospital Universitario Fundación Alcorcón, Madrid, Spain.
- 2Occupational Health Unit, Hospital Universitario Fundación Alcorcón, Madrid, Spain
- 3Laboratory Unit, Hospital Universitario Fundación Alcorcón, Madrid, Spain
- 4Research Unit, Hospital Universitario Fundación Alcorcón, Madrid, Spain
- 5Information System Unit, Hospital Universitario Fundación Alcorcón, Madrid, Spain
- 6Medical Director, Hospital Universitario Fundación Alcorcón, Madrid, Spain
- 7Professor of Medicine. Rey Juan Carlos University. Internal Medicine Unit. Research, Innovation and Education Coordinator. Hospital Universitario Fundación Alcorcón, Madrid, Spain
- ↵*Corresponding author María Velasco, mvelasco{at}fhalcorcon.es, Infectious Diseases. Research Unit. Hospital Universitario Fundación Alcorcón., C/Budapest n°1, 28922 Alcorcón.Madrid. Spain
- ↵†Alternate corresponding author. Carlos Guijarro carlos.guijarro{at}urjc.es, Professor of Medicine. Rey Juan Carlos University., Internal Medicine Unit. Research, Innovation and Education Coordinator. Hospital Universitario Fundación Alcorcón., C/Budapest n°1, 28922 Alcorcón.Madrid. Spain
Posted March 10, 2021.
Impact of previous COVID-19 on immune response after a single dose of BNT162b2 SARS-CoV-2 vaccine
